3 Amendments of Bart STAES related to 2016/2169(DEC)
Amendment 9 #
Motion for a resolution
Paragraph 6 a (new)
Paragraph 6 a (new)
6a. Notes with concern, that despite the 2015 reform, the Agency’s conflict of interests’ policy remains flexible; is especially concerned that revolving doors for experts receiving grants from the private sector have not been prohibited, in the context of the reform for both being hired at the Agency and for the post- employment period;
Amendment 13 #
Motion for a resolution
Paragraph 14 a (new)
Paragraph 14 a (new)
Amendment 22 #
Motion for a resolution
Paragraph 23 a (new)
Paragraph 23 a (new)
23a. Notes that the Agency launched a pilot project on "adaptive pathways" in March 2014 aiming to accelerate market authorisations for specific medicines using the so-called post-marketing authorisation; is concerned that the pilot project raises numerous public health concerns and undermines the core mission of the Agency, namely to ensure safety of medicines; asks the Agency to report to the Discharge Authority on the project and the measures it has taken to ensure that this acceleration of the procedure does not undermine its core mission;